Literature DB >> 18985346

Effect of cyclosporin A administration on the biodistribution and multipinhole muSPECT imaging of [123I]R91150 in rodent brain.

P Blanckaert1, I Burvenich, S Staelens, S De Bruyne, L Moerman, L Wyffels, F De Vos.   

Abstract

PURPOSE: P-glycoprotein (Pgp) is an efflux protein found amongst other locations in the blood-brain barrier. It is important to investigate the effect of Pgp modulation on clinically used brain tracers, because brain uptake of the tracer can be altered by blocking of the Pgp efflux transporter. The function of Pgp can be blocked with cyclosporin A.
METHODS: We investigated the effect of cyclosporin A administration on the biodistribution of [(123)I]R91150 in rodents, and the effect of Pgp blocking on the quality of multipinhole muSPECT imaging with [(123)I]R91150. The influence of increasing doses of cyclosporin A on the brain uptake of [(123)I]R91150 was investigated in NMRI mice. A biodistribution study with [(123)I]R91150 was performed in male Sprague-Dawley rats pretreated with cyclosporin A and not pretreated. Brain uptake of [(123)I]R91150 after cyclosporin A injection was compared to the brain uptake in untreated animals, and a displacement study with ketanserin was performed in both groups. A multipinhole muSPECT brain imaging study was also performed using a Milabs U-SPECT-II camera in male Sprague-Dawley rats. To exclude the effect of possible metabolites, a metabolite study was also performed.
RESULTS: At the highest cyclosporin A dose (50 mg/kg), a sevenfold increase in brain radioactivity concentration was observed in NMRI mice. Also, a dose-response relationship was established between the dose of cyclosporin A and the brain uptake of [(123)I]R91150 in mice. Compared to the control group, a five-fold increase in [(123)I]R91150 radioactivity concentration was observed in the brain of Sprague-Dawley rats after cyclosporin A treatment (50 mg/kg). Radioactivity concentration in the frontal cortex increased from 0.24+/-0.0092 to 1.58+/-0.097% injected dose per gram of tissue after treatment with cyclosporin A (at the 1-h time-point). Blood radioactivity concentrations did not increase to the same extent. The cortical activity was displaced by administration of ketanserin. A metabolite study confirmed that there was no increased metabolism of [(123)I]R91150 due to cyclosporin A. The visual quality of multipinhole muSPECT images with [(123)I]R91150 in Sprague-Dawley rats improved markedly after cyclosporin A pretreatment.
CONCLUSION: From the results obtained in the biodistribution studies, it can be concluded that [(123)I]R91150 is a substrate for Pgp in rodents. A relationship between the administered dose of cyclosporin A and the increase in [(123)I]R91150 brain radioactivity concentration was established. The overall quality of our multipinhole muSPECT images with [(123)I]R91150 in rats improved markedly after pretreatment of the animals with cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985346     DOI: 10.1007/s00259-008-0968-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  26 in total

1.  Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.

Authors:  Jeih-San Liow; Shuiyu Lu; Julie A McCarron; Jinsoo Hong; John L Musachio; Victor W Pike; Robert B Innis; Sami S Zoghbi
Journal:  Synapse       Date:  2007-02       Impact factor: 2.562

2.  In vivo evaluation of P-glycoprotein function at the blood-brain barrier in nonhuman primates using [11C]verapamil.

Authors:  Young-Joo Lee; Jun Maeda; Hiroyuki Kusuhara; Takashi Okauchi; Motoki Inaji; Yuji Nagai; Shigeru Obayashi; Ryuji Nakao; Kazutoshi Suzuki; Yuichi Sugiyama; Tetsuya Suhara
Journal:  J Pharmacol Exp Ther       Date:  2005-11-17       Impact factor: 4.030

3.  In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.

Authors:  Kiichi Ishiwata; Kazunori Kawamura; Kazuhiko Yanai; N Harry Hendrikse
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

4.  1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists.

Authors:  Timo Heinrich; Henning Böttcher; Helmut Prücher; Rudolf Gottschlich; Karl-August Ackermann; Christoph van Amsterdam
Journal:  ChemMedChem       Date:  2006-02       Impact factor: 3.466

5.  Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.

Authors:  Miki Katoh; Naoto Suzuyama; Toshiyuki Takeuchi; Sumie Yoshitomi; Satoru Asahi; Tsuyoshi Yokoi
Journal:  J Pharm Sci       Date:  2006-12       Impact factor: 3.534

Review 6.  Visualization of multidrug resistance in vivo.

Authors:  N H Hendrikse; E J Franssen; W T van der Graaf; W Vaalburg; E G de Vries
Journal:  Eur J Nucl Med       Date:  1999-03

7.  Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.

Authors:  Ana M Catafau; Monica Danus; Santiago Bullich; Jordi Llop; Javier Perich; Vincent J Cunningham; Pedro Plaza; Maria M Penengo; Jos L H Eersels; Lisa Squassante; Domenec Ros; Manel Barbanoj
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

8.  Is MIBG a substrate of P-glycoprotein?

Authors:  Yasushi Kiyono; Tomoko Yamashita; Hisako Doi; Yuji Kuge; Toshiya Katsura; Ken-ichi Inui; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

9.  Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.

Authors:  Brigid Joseph; Kuldeep K Bhargava; Harmeet Malhi; Michael L Schilsky; Diwakar Jain; Christopher J Palestro; Sanjeev Gupta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-21       Impact factor: 9.236

10.  Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.

Authors:  C E Herzog; M Tsokos; S E Bates; A T Fojo
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  4 in total

1.  Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β).

Authors:  Erin L Cole; Xia Shao; Phillip Sherman; Carole Quesada; Maria V Fawaz; Timothy J Desmond; Peter J H Scott
Journal:  Nucl Med Biol       Date:  2014-04-02       Impact factor: 2.408

2.  Absolute quantitative total-body small-animal SPECT with focusing pinholes.

Authors:  Chao Wu; Frans van der Have; Brendan Vastenhouw; Rudi A J O Dierckx; Anne M J Paans; Freek J Beekman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-25       Impact factor: 9.236

3.  Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.

Authors:  Xia Shao; Garrett M Carpenter; Timothy J Desmond; Phillip Sherman; Carole A Quesada; Maria Fawaz; Allen F Brooks; Michael R Kilbourn; Roger L Albin; Kirk A Frey; Peter J H Scott
Journal:  ACS Med Chem Lett       Date:  2012-09-25       Impact factor: 4.345

4.  Performance evaluation of small-animal multipinhole μSPECT scanners for mouse imaging.

Authors:  Steven Deleye; Roel Van Holen; Jeroen Verhaeghe; Stefaan Vandenberghe; Sigrid Stroobants; Steven Staelens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-24       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.